Bristol Myers Squibb has received the FDA’s green light to introduce another immunotherapy-based treatment in first-line ...

ECHELON-3 (NCT04404283) principal investigator Craig A. Portell, MD, speaks to the significance of this triplet approval from ...

Sector - Real Estate fund seekers may want to consider taking a look at Fidelity Real Estate Investment (FRESX). FRESX has a Zacks Mutual Fund Rank of 3 (Hold), which is based on various forecasting ...